Dataset Information

A machine learning approach for genome-wide prediction of morbid and druggable human genes based on systems-level data.

ABSTRACT: BACKGROUND: The genome-wide identification of both morbid genes, i.e., those genes whose mutations cause hereditary human diseases, and druggable genes, i.e., genes coding for proteins whose modulation by small molecules elicits phenotypic effects, requires experimental approaches that are time-consuming and laborious. Thus, a computational approach which could accurately predict such genes on a genome-wide scale would be invaluable for accelerating the pace of discovery of causal relationships between genes and diseases as well as the determination of druggability of gene products. RESULTS: In this paper we propose a machine learning-based computational approach to predict morbid and druggable genes on a genome-wide scale. For this purpose, we constructed a decision tree-based meta-classifier and trained it on datasets containing, for each morbid and druggable gene, network topological features, tissue expression profile and subcellular localization data as learning attributes. This meta-classifier correctly recovered 65% of known morbid genes with a precision of 66% and correctly recovered 78% of known druggable genes with a precision of 75%. It was than used to assign morbidity and druggability scores to genes not known to be morbid and druggable and we showed a good match between these scores and literature data. Finally, we generated decision trees by training the J48 algorithm on the morbidity and druggability datasets to discover cellular rules for morbidity and druggability and, among the rules, we found that the number of regulating transcription factors and plasma membrane localization are the most important factors to morbidity and druggability, respectively. CONCLUSIONS: We were able to demonstrate that network topological features along with tissue expression profile and subcellular localization can reliably predict human morbid and druggable genes on a genome-wide scale. Moreover, by constructing decision trees based on these data, we could discover cellular rules governing morbidity and druggability.

SUBMITTER: Costa PR

PROVIDER: S-EPMC3045802 | biostudies-literature | 2010

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

A machine learning approach for genome-wide prediction of morbid and druggable human genes based on systems-level data.

Costa Pedro R PR Acencio Marcio L ML Lemke Ney N

BMC genomics 20101222

<h4>Background</h4>The genome-wide identification of both morbid genes, i.e., those genes whose mutations cause hereditary human diseases, and druggable genes, i.e., genes coding for proteins whose modulation by small molecules elicits phenotypic effects, requires experimental approaches that are time-consuming and laborious. Thus, a computational approach which could accurately predict such genes on a genome-wide scale would be invaluable for accelerating the pace of discovery of causal relatio ...[more]

PMID: 21210975

Similar Datasets

Project description:California's almond growers face challenges with nitrogen management as new legislatively mandated nitrogen management strategies for almond have been implemented. These regulations require that growers apply nitrogen to meet, but not exceed, the annual N demand for crop and tree growth and nut production. To accurately predict seasonal nitrogen demand, therefore, growers need to estimate block-level almond yield early in the growing season so that timely N management decisions can be made. However, methods to predict almond yield are not currently available. To fill this gap, we have developed statistical models using the Stochastic Gradient Boosting, a machine learning approach, for early season yield projection and mid-season yield update over individual orchard blocks. We collected yield records of 185 orchards, dating back to 2005, from the major almond growers in the Central Valley of California. A large set of variables were extracted as predictors, including weather and orchard characteristics from remote sensing imagery. Our results showed that the predicted orchard-level yield agreed well with the independent yield records. For both the early season (March) and mid-season (June) predictions, a coefficient of determination (R 2) of 0.71, and a ratio of performance to interquartile distance (RPIQ) of 2.6 were found on average. We also identified several key determinants of yield based on the modeling results. Almond yield increased dramatically with the orchard age until about 7 years old in general, and the higher long-term mean maximum temperature during April-June enhanced the yield in the southern orchards, while a larger amount of precipitation in March reduced the yield, especially in northern orchards. Remote sensing metrics such as annual maximum vegetation indices were also dominant variables for predicting the yield potential. While these results are promising, further refinement is needed; the availability of larger data sets and incorporation of additional variables and methodologies will be required for the model to be used as a fertilization decision support tool for growers. Our study has demonstrated the potential of automatic almond yield prediction to assist growers to manage N adaptively, comply with mandated requirements, and ensure industry sustainability.

Project description:Different types of chemicals and products may exhibit various health risks when administered into the human body. For toxicity reasons, the number of new drugs entering the market through the conventional drug development process has been reduced over the years. However, with the advent of big data and artificial intelligence, machine learning techniques have emerged as a potential solution for predicting toxicity and ensuring efficient drug development and chemical safety. An ML model for toxicity prediction can reduce experimental costs and time while addressing ethical concerns by drastically reducing the need for animals and clinical trials. Herein, MolToxPred, an ML-based tool, has been developed using a stacked model approach to predict the potential toxicity of small molecules and metabolites. The stacked model consists of random forest, multi-layer perceptron, and LightGBM as base classifiers and Logistic Regression as the meta classifier. For training and validation purposes, a comprehensive set of toxic and non-toxic molecules is curated. Different structural and physicochemical-based features in the form of molecular descriptors and fingerprints were employed. MolToxPred utilizes a comprehensive feature selection process and optimizes its hyperparameters through Bayesian optimization with stratified 5-fold cross-validation. In the evaluation phase, MolToxPred achieved an AUROC of 87.76% on the test set and 88.84% on an external validation set. The McNemar test was used as the post-hoc test to determine if the stacked models' performance was significantly different compared to the base learners. The developed stacked model outperformed its base classifiers and an existing tool in the literature, reaffirming its better performance. The hypothesis is that the incorporation of a diverse set of data, the subsequent feature selection, and a stacked ensemble approach give MolToxPred the edge over other methods. In addition to this, an attempt has been made to identify structural alerts responsible for endpoints of the Tox21 data to determine the association of a molecule with a plausible downstream pathway of action. MolToxPred may be helpful for drug discovery and regulatory pipelines in pharmaceutical and other industries for in silico toxicity prediction of small molecule candidates.

Project description:BackgroundVirtually all currently available microRNA target site prediction algorithms require the presence of a (conserved) seed match to the 5' end of the microRNA. Recently however, it has been shown that this requirement might be too stringent, leading to a substantial number of missed target sites.ResultsWe developed TargetSpy, a novel computational approach for predicting target sites regardless of the presence of a seed match. It is based on machine learning and automatic feature selection using a wide spectrum of compositional, structural, and base pairing features covering current biological knowledge. Our model does not rely on evolutionary conservation, which allows the detection of species-specific interactions and makes TargetSpy suitable for analyzing unconserved genomic sequences.In order to allow for an unbiased comparison of TargetSpy to other methods, we classified all algorithms into three groups: I) no seed match requirement, II) seed match requirement, and III) conserved seed match requirement. TargetSpy predictions for classes II and III are generated by appropriate postfiltering. On a human dataset revealing fold-change in protein production for five selected microRNAs our method shows superior performance in all classes. In Drosophila melanogaster not only our class II and III predictions are on par with other algorithms, but notably the class I (no-seed) predictions are just marginally less accurate. We estimate that TargetSpy predicts between 26 and 112 functional target sites without a seed match per microRNA that are missed by all other currently available algorithms.ConclusionOnly a few algorithms can predict target sites without demanding a seed match and TargetSpy demonstrates a substantial improvement in prediction accuracy in that class. Furthermore, when conservation and the presence of a seed match are required, the performance is comparable with state-of-the-art algorithms. TargetSpy was trained on mouse and performs well in human and drosophila, suggesting that it may be applicable to a broad range of species. Moreover, we have demonstrated that the application of machine learning techniques in combination with upcoming deep sequencing data results in a powerful microRNA target site prediction tool http://www.targetspy.org.

Dataset Information

A machine learning approach for genome-wide prediction of morbid and druggable human genes based on systems-level data.

Publications

A machine learning approach for genome-wide prediction of morbid and druggable human genes based on systems-level data.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets